How bacteria take shape
One possible route towards finding new antibiotics to counter pneumococci may be by developing a substance that effectively hinders the process of cell division. A research team led by Jan-Willem Veening of the Department of Molecular Genetics of the University of Groningen has recently identified a protein named StkP, which plays an important role in this process.
An intriguing question is how oval bacteria, such as the human pathogen Streptococcus pneumoniae (pneumococcus), know when to divide in order to avoid producing round or elongated daughter cells.
The researchers used biochemical and microscopic technologies to prove that StkP migrates to the centre of the cell, where it regulates important proteins that are involved in cell division. If StkP is absent, the pneumococci lose their characteristic oval shape and become rod-shaped. These rod-shaped pneumococci are less virulent because the human immune system finds them easier to recognize. Since StkP is present in all pathogenic pneumococci and is an essential ingredient in their virulence, this protein would be an excellent candidate for the development of new antibiotics.
An article about this study has been published in PNAS.
Further information:
Dr J.W. Veening, Assistant Professor of Molecular Genetics at the Groningen Biomolecular Sciences and Biotechnology Institute and Centre for Synthetic Biology of the University of Groningen, j.w.veening rug.nl , tel. 050-363 2408
Last modified: | 22 August 2024 1.32 p.m. |
More news
-
01 July 2025
‘Give them space’
The Wadden Sea is constantly changing. Native animals need to be able to adapt in order to thrive in an environment that is shaped by the tides. By conducting research on seals in the area, PhD students Margarita Méndez-Aróstegui and Beatriz...
-
30 June 2025
David Lentink partners international research project on animal navigation
Prof. David Lentink is a partner in the NaviSense project awarded 54.7 million euros by the German government to research the mechanisms animals use to navigate and how these mechanisms can inspire technology.
-
26 June 2025
Prof. Adri Minnaard receives RSC Chemistry Biology Interface Horizon Prize with Lipidomics team
With the ‘Lipidomics Team’, Prof. Adri Minnaard has been named winner of the Chemistry Biology Interface Horizon Prize of the Royal Society of Chemistry (RSC).